Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Emily Prokop"'
Publikováno v:
Library Journal. November 2024 Reference, Vol. 149 Issue 11, p55-55. 1p. 12 Color Photographs.
Publikováno v:
The Journal of Immunology. 210:1292-1304
It is generally accepted that influenza A virus (IAV) infection promotes a Th1-like CD4 T cell response and that this effector program underlies its protective impact. Canonical Th1 polarization requires cytokine-mediated activation of the transcript
Autor:
Kunal Dhume, Caroline M. Finn, Priyadharshini Devarajan, Ayushi Singh, Joanne D. Tejero, Emily Prokop, Tara M. Strutt, Stewart Sell, Susan L. Swain, Karl Kai McKinstry
Publikováno v:
J Immunol
Optimal transcriptional programming needed for CD4 T cells to protect against influenza A virus (IAV) is unclear. Most IAV-primed CD4 T cells fit Th1 criteria. However, cells deficient for the Th1 “master regulator,” T-bet, although marked by red
Publikováno v:
The Journal of Immunology. 208:182.13-182.13
Influenza A virus (IAV)-specific memory T cells induced by infection or through vaccination with live attenuated cold adapted influenza virus (LAIV) vaccine strains are well known to be able to confer protection against secondary homotypic as well as
Publikováno v:
The Journal of Immunology. 208:114.04-114.04
CD4+ tissue-resident memory (TRM) T cells act as sentinels at previous sites of infection and rapidly initiate protective inflammatory responses upon antigen re-encounter. Here, we tested if beyond local impacts in the lung, TRM responses lead to fas
Autor:
Emily Prokop
Learn the fascinating history and trivia behind the everyday items we take for granted—from the host of the popular podcast The Story Behind. Many of us learn about the major inventions that shape our world. But we too often overlook the objects w
Publikováno v:
The Journal of Immunology. 206:103.08-103.08
Interleukin-2 is a pleotropic cytokine with potent pro- and anti-inflammatory effects. These divergent impacts can be directed in vivo by forming complexes of recombinant IL-2 and anti-IL-2 monoclonal antibodies (IL-2C) to target IL-2 to distinct sub
Publikováno v:
Vaccine Weekly; 3/31/2023, p417-417, 1p